Mutations in PNKP cause microcephaly, seizures and defects in DNA repair
- PMID:20118933
- PMCID: PMC2835984
- DOI: 10.1038/ng.526
Mutations in PNKP cause microcephaly, seizures and defects in DNA repair
Abstract
Maintenance of DNA integrity is crucial for all cell types, but neurons are particularly sensitive to mutations in DNA repair genes, which lead to both abnormal development and neurodegeneration. We describe a previously unknown autosomal recessive disease characterized by microcephaly, early-onset, intractable seizures and developmental delay (denoted MCSZ). Using genome-wide linkage analysis in consanguineous families, we mapped the disease locus to chromosome 19q13.33 and identified multiple mutations in PNKP (polynucleotide kinase 3'-phosphatase) that result in severe neurological disease; in contrast, a splicing mutation is associated with more moderate symptoms. Unexpectedly, although the cells of individuals carrying this mutation are sensitive to radiation and other DNA-damaging agents, no such individual has yet developed cancer or immunodeficiency. Unlike other DNA repair defects that affect humans, PNKP mutations universally cause severe seizures. The neurological abnormalities in individuals with MCSZ may reflect a role for PNKP in several DNA repair pathways.
Figures





Comment in
- DNA repair deficiency in a newly identified neurological disease.Huang K.Huang K.Clin Genet. 2010 Nov;78(5):418-9. doi: 10.1111/j.1399-0004.2010.01519_1.x. Epub 2010 Aug 26.Clin Genet. 2010.PMID:20738333No abstract available.
Similar articles
- Impact of PNKP mutations associated with microcephaly, seizures and developmental delay on enzyme activity and DNA strand break repair.Reynolds JJ, Walker AK, Gilmore EC, Walsh CA, Caldecott KW.Reynolds JJ, et al.Nucleic Acids Res. 2012 Aug;40(14):6608-19. doi: 10.1093/nar/gks318. Epub 2012 Apr 15.Nucleic Acids Res. 2012.PMID:22508754Free PMC article.
- The Phenotypic Spectrum of PNKP-Associated Disease and the Absence of Immunodeficiency and Cancer Predisposition in a Dutch Cohort.Garrelfs MR, Takada S, Kamsteeg EJ, Pegge S, Mancini G, Engelen M, van de Warrenburg B, Rennings A, van Gaalen J, Peters I, Weemaes C, van der Burg M, Willemsen MA.Garrelfs MR, et al.Pediatr Neurol. 2020 Dec;113:26-32. doi: 10.1016/j.pediatrneurol.2020.07.014. Epub 2020 Jul 28.Pediatr Neurol. 2020.PMID:32980744
- Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease.Dumitrache LC, McKinnon PJ.Dumitrache LC, et al.Mech Ageing Dev. 2017 Jan;161(Pt A):121-129. doi: 10.1016/j.mad.2016.04.009. Epub 2016 Apr 26.Mech Ageing Dev. 2017.PMID:27125728Free PMC article.Review.
- Causative novel PNKP mutations and concomitant PCDH15 mutations in a patient with microcephaly with early-onset seizures and developmental delay syndrome and hearing loss.Nakashima M, Takano K, Osaka H, Aida N, Tsurusaki Y, Miyake N, Saitsu H, Matsumoto N.Nakashima M, et al.J Hum Genet. 2014 Aug;59(8):471-4. doi: 10.1038/jhg.2014.51. Epub 2014 Jun 26.J Hum Genet. 2014.PMID:24965255
- Microcephalic primordial dwarfism in an Emirati patient with PNKP mutation.Nair P, Hamzeh AR, Mohamed M, Saif F, Tawfiq N, El Halik M, Al-Ali MT, Bastaki F.Nair P, et al.Am J Med Genet A. 2016 Aug;170(8):2127-32. doi: 10.1002/ajmg.a.37766. Epub 2016 May 27.Am J Med Genet A. 2016.PMID:27232581Review.
Cited by
- Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor.Jiang B, Murray C, Cole BL, Glover JNM, Chan GK, Deschenes J, Mani RS, Subedi S, Nerva JD, Wang AC, Lockwood CM, Mefford HC, Leary SES, Ojemann JG, Weinfeld M, Ene CI.Jiang B, et al.Sci Rep. 2022 Mar 30;12(1):5386. doi: 10.1038/s41598-022-09097-w.Sci Rep. 2022.PMID:35354845Free PMC article.
- Impact of DNA repair and stability defects on cortical development.Bianchi FT, Berto GE, Di Cunto F.Bianchi FT, et al.Cell Mol Life Sci. 2018 Nov;75(21):3963-3976. doi: 10.1007/s00018-018-2900-2. Epub 2018 Aug 16.Cell Mol Life Sci. 2018.PMID:30116853Free PMC article.Review.
- Tidying up loose ends: the role of polynucleotide kinase/phosphatase in DNA strand break repair.Weinfeld M, Mani RS, Abdou I, Aceytuno RD, Glover JN.Weinfeld M, et al.Trends Biochem Sci. 2011 May;36(5):262-71. doi: 10.1016/j.tibs.2011.01.006. Epub 2011 Feb 25.Trends Biochem Sci. 2011.PMID:21353781Free PMC article.Review.
- Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases.Li X, Cao G, Liu X, Tang TS, Guo C, Liu H.Li X, et al.Front Cell Neurosci. 2022 Jun 30;16:852002. doi: 10.3389/fncel.2022.852002. eCollection 2022.Front Cell Neurosci. 2022.PMID:35846567Free PMC article.Review.
- Pathological mutations in PNKP trigger defects in DNA single-strand break repair but not DNA double-strand break repair.Kalasova I, Hailstone R, Bublitz J, Bogantes J, Hofmann W, Leal A, Hanzlikova H, Caldecott KW.Kalasova I, et al.Nucleic Acids Res. 2020 Jul 9;48(12):6672-6684. doi: 10.1093/nar/gkaa489.Nucleic Acids Res. 2020.PMID:32504494Free PMC article.
References
- Huo YK, et al. Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. Cancer Res. 1994;54:2544–7. - PubMed
- Sun X, et al. Early diagnosis of ataxia-telangiectasia using radiosensitivity testing. J Pediatr. 2002;140:724–31. - PubMed
- Jilani A, et al. Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3′-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage. J Biol Chem. 1999;274:24176–86. - PubMed
- Karimi-Busheri F, et al. Molecular characterization of a human DNA kinase. J Biol Chem. 1999;274:24187–94. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
- G9900837/MRC_/Medical Research Council/United Kingdom
- R21 TW008223-02/TW/FIC NIH HHS/United States
- R01 NS035129-12/NS/NINDS NIH HHS/United States
- K12 HD052896/HD/NICHD NIH HHS/United States
- R21 NS061772/NS/NINDS NIH HHS/United States
- G0700089/MRC_/Medical Research Council/United Kingdom
- G0600776/MRC_/Medical Research Council/United Kingdom
- P30 HD018655/HD/NICHD NIH HHS/United States
- R01 NS035129/NS/NINDS NIH HHS/United States
- HHSN268200782096C/HL/NHLBI NIH HHS/United States
- 5K08NS059673-02/NS/NINDS NIH HHS/United States
- G0400959/MRC_/Medical Research Council/United Kingdom
- HHMI/Howard Hughes Medical Institute/United States
- NIH N01-HG-65403/HG/NHGRI NIH HHS/United States
- N01HG65403/HG/NHGRI NIH HHS/United States
- 1 K12 HD052896-01A1/HD/NICHD NIH HHS/United States
- K12 HD052896-01A1/HD/NICHD NIH HHS/United States
- T32 GM007753/GM/NIGMS NIH HHS/United States
- K08 NS059673/NS/NINDS NIH HHS/United States
- P30 HD18655/HD/NICHD NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R21 TW008223/TW/FIC NIH HHS/United States
- K08 NS059673-03/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases